Please login to the form below

Not currently logged in
Email:
Password:

biosimilars

This page shows the latest biosimilars news and features for those working in and with pharma, biotech and healthcare.

Novartis builds its case for novel MS treatment ofatumumab

Novartis builds its case for novel MS treatment ofatumumab

biosimilar competition in the US and Europe.

Latest news

More from news
Approximately 137 fully matching, plus 347 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    It faces multiple competitors across both oral and injectable therapies, as well as a stiff pricing environment due to the presence of generics and biosimilars. ... The drug must leverage its competitive profile as it will face significant competition

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    biosimilars and other lower-cost drugs and health concerns relating to vaping products.

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    in 2023, and is starting to feel the effects of biosimilar competition to the brand in Europe. ... The latter is still low level, however, and biosimilars to Botox are thought to be some years off the market.

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    Commitment issues. By most estimates, the US is about a decade behind the EU in terms of adopting biosimilars, with 90% of all global biosimilar sales occurring in EU countries, even ... Gottlieb, in remarks made at the release of the FDA’s Biosimilar

  • The Golden Goose The Golden Goose

    Biosimilar fail. Another stumbling block has been our over-reliance on market-based solutions to this problem, ie, generics. ... The thinking was at that time we’d solved the biosimilar problem, and here we are nine years later saying, no, we haven’t.

More from intelligence
Approximately 12 fully matching, plus 60 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest from PMHub

  • Are biobetters a market access opportunity?

    This produces time pressure for biobetters to make it to market before a biosimilar, to avoid the downward price pressure a biosimilar creates. ... Moreover, biobetters will need to enter the market before the exclusivity period of the patented reference

  • How to weather the pricing competiton How to weather the pricing competiton

    deal. The simulated market becomes highly competitive with the entrance of a better value product and then later a biosimilar/generic competitor.

  • Launch Excellence 2020

    In the past year, the competition in biosimilars and complex generics has complicated the launch landscape.

  • The 'winner takes all' pricing game

    Conclusions. Pharmaceutical tendering will stay as a key procurement approach for pharmaceutical products, especially for hospital products but also in outpatient settings for generics/biosimilars or other segments of products with

  • How ready are you for launch?

    Specifically, it has focused its efforts on increasing competition in biosimilars and complex generics, which are difficult to copy, in a bid to increase competition and drive down prices.

More from PMHub
Approximately 12 fully matching, plus 27 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics